TP53 and cancer: Only 14% of significant associations of a given molecular target to driver gene alteration status were shared between two analyses (Additional file 1: Fig. S10c), indicating that considering TP53 status strongly alters the drug-gene links that can be recovered from statistical testing of drug screens on cancer cell lines.